Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

o increase between 30% and 40% from 2008 to the range from $16.6 million to $17.9 million.

    Highlights of Recent Developments
    -- Management has decided to start the construction of Inner Mongolia
       plant buildings on May 9, 2009 and to attempt to complete it by the end
       of 2009.
    -- In addition to the cost of land use rights and related expenses
       (approximately $32.6 million) which Liang Fang has paid, other
       components of the project are yet to be funded, including construction
       costs of approximately $17.5 million, costs associated with the various
       production lines estimated at approximately $33.6 million and working
       capital of approximately $7.3 million.
    -- The Company entered into an intellectual rights transfer contract with
       Beijing Yipuan Bio-Medical Technology Co., Ltd. in December 2008 to
       acquire the drug Yipubishan, a highly effective and stable octreotide
       acetate injection solution, In the first quarter of 2009, the Company
       has paid up $7.9 million as required in the transfer. The Company
       believes this could contribute $11.0 million to 2009's sale revenues
       with net margin of 75%.
    -- The Company announced two drugs entering into clinical testing of SFDA
       in 2008, Isosorbide Mononitrate sustained release tablet, a highly
       effective drug for the prevention and treatment of angina; and
       Laevo-Bambutero a Class 1 drug to treat asthma.
    -- Lotus obtained the patent, along with exclusive production rights for
       Laevo-Bambutero in China, through the technology transfer agreement
       with Dongguan Kaifa for a cash payment of $7.0 million and a 3% royalty
       on products sales. The Company has already paid $2.9 million to
       Dongguan Kaifa. The Company intends to market Laevo-Bambutero as a
       better alternative to Bambutero for the treatment of asthma, since it
       uses an integra
'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-FirstCall/--TheAdvisoryBoardCompany(Nasdaq:...tAnnualPiperJaffrayHealthCareConferenceinNewYorkCi...M(EST),willbetheCompany,sChiefExecutiveOfficer,Rob...cer,MichaelT.Kirshbaum.Thepresentationmaterialswil...ww.advisoryboardcompany.com ,throughDecember16,200...
(Date:11/25/2009)...RNewswire/--DanielTouizer,CEOof Ci n e r gyHe...nsurancebenefitprograms,isconcernedthatthelabordep...fiveAmericansarewithoutafull-timejobandunlikelytoh...edeterminedbytheU-6number,whichhasspikedto17.5%,th...izer ."Thesestatisticsarealarmingasitmeansthatman...
(Date:11/25/2009)... Melvin R. Kaplan, MD, FACP, a former Board Chair ...that became Los Angeles Biomedical Research Instit...l be honored by the American College of Physicians.... , At its April 22, 2010 meeting in Toronto, th...Kaplan with the Ralph O. Claypoole Sr. Memorial Aw...
(Date:11/25/2009)... success for patients with liver lesions, research...ay News) -- Adding the drug cetuximab to neoadjuva...ds of successful surgery in colorectal cancer pati... research suggests. , , Tumors spread to other...ith colorectal cancer. Most commonly, the cancer s...
(Date:11/25/2009)...PRNewswire-FirstCall/-- TheProvidenceServiceCorpo...aresubsidiary,thenation,slargestcoordinatorofnon-e...iceofawardfromtheStateofFloridaCommissionfortheTra...encytransportationservicestobothMiami-DadeandVolus...revenueovertheinitial18monthterm,issubjecttofinali...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3
...r, researchers studying eight cross-gender heart t...overed that the body can actively reshape the hear...tanding belief that the heart cannot repair itself...er organs came after Dr. Federico Quaini and his c...
... amount of fruit and vegetables, but they are stil...ruits and vegetables acts as a booster to our huma...g fruit and veg// at least five times a day increa...ase was from 20 per cent to 25 per cent during thi...
...eath in the United States, after heart disease and...ry year, and 167,000 die from it. Men who suffer f...es as likely// to die from a stroke as other men. ...r 14 years.They found the men with depression or s...
...larly women, may have an increased risk of develop...chers studied almost 100,000 patients who had been... the patients showed any signs of cancer at their ...study’s conclusion, the researchers found that lun...
...rt all reduce the risk of Alzheimer's disease, acc...attainment has already been associated with reduce...eisure activities, too, protect against cognitive ... the participants about their intellectual, social...
...uring her pregnancy, the special form of the disea...and her baby at risk. Moms can develop high blood ...risk for lung problems and occasionally die. To ke... Researchers in Australia and New Zealand found t...
Other Medicine News:
(Date:11/25/2009)...v.25/PRNewswire/--SwissrayInternational,Inc.aleadi...tems,announcedtodaythatitsoperationshavebeenacquir...rowingSwissray,smedicalimagingbrand.Theacquisition...ontractsandinventory.After25yearsofsuccessandgrowt...gicaladvancementswithstableandsteadygrowth. ,, ...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...ewswire/-- ,, WHAT:RomHoubens,aBelgianmanthough...,wasactuallyfullyconsciousandawakeduringthattimean...VoxEyeMaxwasfeaturedinthesegmenttoillustratehowpeo...kcommunication. ,, WHEN:GoodMorningAmerica-- Tu...ech.com ,, WHO:RomHoubenswasanengineeringst...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 3Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 1IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 2
...loping Embryonic Stem Cell Lines for Therapeutic ...C., Jan. 17 A California research team has,become...the cloning of a,human embryo using donated oocyte...onor. The study was published online today by the ....com/cgi-bin/prnh/20080117/CLTH022LOGO ), The ex...
...Vical Incorporated,(Nasdaq: VICL ) today announce...AnGes MG, Inc. for costs associated with the ongoi...c Melanoma (AIMM) Phase 3 trial., AnGes is fundin...er a,previously announced collaborative agreement ...uity investments totaling $22.6 million, for which...
Other Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 2Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 3
Coolscope
Eclipse E400
...e the slight change in the difficulty score for ea...orrected visual acuity examinations of 7420 eyes d...lty scores were derived from the examination of 23...letters which resulted in the ultimate homogeneity...
Cube Stereogram Stereo Test
Medicine Products: